Cell Source Stock Price on December 23, 2024
| CLCS Stock | USD 0.50 0.02 4.17% |
If you're considering investing in Cell OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cell Source stands at 0.50, as last reported on the 23rd of December, with the highest price reaching 0.50 and the lowest price hitting 0.50 during the day. Cell Source is out of control given 3 months investment horizon. Cell Source secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of risk over the last 3 months. We were able to break down twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.8% are justified by taking the suggested risk. Use Cell Source Mean Deviation of 10.0, risk adjusted performance of 0.0843, and Downside Deviation of 15.55 to evaluate company specific risk that cannot be diversified away.
Cell OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cell |
Sharpe Ratio = 0.1078
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CLCS | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.72 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.8 actual daily | 35 65% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Cell Source is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cell Source by adding it to a well-diversified portfolio.
Cell Source Valuation on December 23, 2024
It is possible to determine the worth of Cell Source on a given historical date. On December 23, 2024 Cell was worth 0.5 at the beginning of the trading date compared to the closed value of 0.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cell Source otc stock. Still, in general, we apply an absolute valuation method to find Cell Source's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cell Source where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cell Source's related companies.
| Open | High | Low | Close | Volume | |
| 0.50 | 0.50 | 0.50 | 0.50 | 1.00 | |
12/23/2024 | 0.50 | 0.50 | 0.50 | 0.50 | 0.00 |
| Backtest Cell Source | | | Cell Source History | | | Cell Source Valuation | Previous |
Cell Source Trading Date Momentum on December 23, 2024
| On December 23 2024 Cell Source was traded for 0.50 at the closing time. The top price for the day was 0.50 and the lowest listed price was 0.50 . There was no trading activity during the period 0.0. Lack of trading volume on December 23, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Cell Source Fundamentals Correlations and Trends
By evaluating Cell Source's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cell Source's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cell Source OTC Stock history
Cell Source investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cell Source will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cell Source stock prices may prove useful in developing a viable investing in Cell Source
Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. Cell Source, Inc. was founded in 2012 and is headquartered in New York, New York. Cell Source operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
Cell Source OTC Stock Technical Analysis
Cell Source technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Cell Source Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Cell Source cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cell Source December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Cell Source otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cell Source shares will generate the highest return on investment. By undertsting and applying Cell Source otc stock market strength indicators, traders can identify Cell Source entry and exit signals to maximize returns
Cell Source Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cell Source's price direction in advance. Along with the technical and fundamental analysis of Cell OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0843 | |||
| Jensen Alpha | 1.57 | |||
| Total Risk Alpha | 1.09 | |||
| Sortino Ratio | 0.0986 | |||
| Treynor Ratio | (3.23) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cell OTC Stock Analysis
When running Cell Source's price analysis, check to measure Cell Source's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Source is operating at the current time. Most of Cell Source's value examination focuses on studying past and present price action to predict the probability of Cell Source's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Source's price. Additionally, you may evaluate how the addition of Cell Source to your portfolios can decrease your overall portfolio volatility.